Drugmakers challenge paroxetine case at ECJ

Six pharmaceutical companies have questioned the UK Competition and Markets Authority’s framework for analysing pay-for-delay settlements, as the European Commission defended its national counterpart before the European Court of Justice.


Get unlimited access to all Global Competition Review content